VERTEX PHARMACEUTICALS INC / MA Initial Statement of Beneficial Ownership
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
This article details the initial statement of beneficial ownership (Form 3) filed by Daniel J. Brennan for VERTEX PHARMACEUTICALS INC / MA (VRTX). The filing indicates Brennan's relationship to the issuer as a Director, with the event requiring the statement dated October 20, 2026. According to the document, no securities are beneficially owned by Brennan at this initial filing.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.